Xenon Pharmaceuticals Inc. Logo

Xenon Pharmaceuticals Inc.

A neuroscience biopharma developing novel therapeutics for epilepsy and depression.

XENE | US

Overview

Corporate Details

ISIN(s):
CA98420N1050
LEI:
Country:
United States of America
Address:
200 - 3650 GILMORE WAY, 0 BURNABY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapeutics. The company is committed to improving the lives of individuals with neurological and psychiatric disorders by addressing areas of high unmet medical need. Its core activity involves advancing a novel product pipeline with a focus on conditions such as epilepsy and depression.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Xenon Pharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Xenon Pharmaceuticals Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Xenon Pharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Revolution Medicines, Inc. Logo
A clinical-stage oncology company developing targeted therapies for RAS-addicted cancers.
United States of America
RVMD
REVVITY, INC. Logo
Provides life sciences & diagnostics technologies to support workflows from discovery to cure.
United States of America
RVTY
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea
102460
Rezolute, Inc. Logo
Developing therapies for rare metabolic diseases, focusing on hyperinsulinism-caused hypoglycemia.
United States of America
RZLT
RHYTHM PHARMACEUTICALS, INC. Logo
Develops precision medicines for rare genetic diseases causing severe obesity and hyperphagia.
United States of America
RYTM
RIGEL PHARMACEUTICALS INC Logo
Develops and commercializes small-molecule drugs for hematology, cancer, and autoimmune diseases.
United States of America
RIGL
Roche Holding AG Logo
A global leader in pharmaceuticals and diagnostics, pioneering personalized healthcare solutions.
Switzerland
RO
ROCKET PHARMACEUTICALS, INC. Logo
Developing LV/AAV gene therapies for rare genetic bone marrow and cardiovascular diseases.
United States of America
RCKT
ROHTO PHARMACEUTICAL CO.,LTD. Logo
Manufactures OTC drugs, skincare, and cosmetics with a focus on eye and dermatological health.
Japan
4527
Roivant Sciences Ltd. Logo
Accelerates medicine and tech development by building agile, focused subsidiary companies.
United States of America
ROIV

Talk to a Data Expert

Have a question? We'll get back to you promptly.